{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:59:28Z","timestamp":1794574768563,"version":"4.9.1"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2022YFC2303000"],"award-info":[{"award-number":["2022YFC2303000"]}]},{"name":"National Key Research and Development Program of China","award":["2021YFC2300400"],"award-info":[{"award-number":["2021YFC2300400"]}]},{"name":"CAS Interdisciplinary Innovation Team"},{"DOI":"10.13039\/501100009010","name":"Henan Agricultural University","doi-asserted-by":"publisher","award":["30900880"],"award-info":[{"award-number":["30900880"]}],"id":[{"id":"10.13039\/501100009010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009010","name":"Henan Agricultural University","doi-asserted-by":"publisher","award":["30500946"],"award-info":[{"award-number":["30500946"]}],"id":[{"id":"10.13039\/501100009010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Poverty"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Emerging fungal pathogens pose important threats to global public health. The World Health Organization has responded to the rising threat of traditionally neglected fungal infections by developing a Fungal Priority Pathogens List (FPPL). Taking the highest-ranked fungal pathogen in the FPPL,\n                      <jats:italic>Cryptococcus neoformans<\/jats:italic>\n                      , as a paradigm, we review progress made over the past two decades on its global burden, its clinical manifestation and management of cryptococcal infection, and its antifungal resistance. The purpose of this review is to drive research efforts to improve future diagnoses, therapies, and interventions associated with fungal infections.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We first reviewed trends in the global burden of HIV-associated cryptococcal infection, mainly based on a series of systematic studies. We next conducted scoping reviews in accordance with the guidelines described in the Preferred Reporting Items for Systematic Reviews and Meta-analyses extension for Scoping Reviews using PubMed and ScienceDirect with the keyword\n                      <jats:italic>Cryptococcus neoformans<\/jats:italic>\n                      \u00a0to identify case reports of cryptococcal infections published since 2000. We then reviewed recent updates on the diagnosis and antifungal treatment of cryptococcal infections. Finally, we summarized knowledge regarding the resistance and tolerance of\n                      <jats:italic>C. neoformans<\/jats:italic>\n                      to approved antifungal drugs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There has been a general reduction in the estimated global burden of HIV-associated cryptococcal meningitis since 2009, probably due to improvements in highly active antiretroviral therapies. However, cryptococcal meningitis still accounts for 19% of AIDS-related deaths annually. The incidences of CM in Europe and North America and the Latin America region have increased by approximately two-fold since 2009, while other regions showed either reduced or stable numbers of cases. Unfortunately, diagnostic and treatment options for cryptococcal infections are limited, and emerging antifungal resistance exacerbates the public health burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The rising threat of\n                      <jats:italic>C. neoformans<\/jats:italic>\n                      is compounded by accumulating evidence for its ability to infect immunocompetent individuals and the emergence of antifungal-resistant variants. Emphasis should be placed on further understanding the mechanisms of pathogenicity and of antifungal resistance and tolerance. The development of novel management strategies through the identification of new drug targets and the discovery and optimization of new and existing diagnostics and therapeutics are key to reducing the health burden.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40249-023-01073-4","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T02:02:57Z","timestamp":1679018577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":189,"title":["Cryptococcus neoformans, a global threat to human health"],"prefix":"10.1186","volume":"12","author":[{"given":"Youbao","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leixin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fujie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenguo","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxin","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukai","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojian","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqing","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5243-341X","authenticated-orcid":false,"given":"Linqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"key":"1073_CR1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1126\/science.287.5452.443","volume":"287","author":"P Daszak","year":"2000","unstructured":"Daszak P, Cunningham AA, Hyatt AD. Emerging infectious diseases of wildlife\u2014threats to biodiversity and human health. Science. 2000;287:443\u20139.","journal-title":"Science"},{"key":"1073_CR2","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/j.1523-1739.2006.00524.x","volume":"20","author":"KF Smith","year":"2006","unstructured":"Smith KF, Sax DF, Lafferty KD. Evidence for the role of infectious disease in species extinction and endangerment. Conserv Biol. 2006;20:1349\u201357.","journal-title":"Conserv Biol"},{"key":"1073_CR3","doi-asserted-by":"publisher","first-page":"e1009503","DOI":"10.1371\/journal.ppat.1009503","volume":"17","author":"NE Nnadi","year":"2021","unstructured":"Nnadi NE, Carter DA. Climate change and the emergence of fungal pathogens. PLoS Pathog. 2021;17:e1009503.","journal-title":"PLoS Pathog"},{"key":"1073_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.envint.2015.09.007","volume":"86","author":"X Wu","year":"2016","unstructured":"Wu X, Lu Y, Zhou S, Chen L, Xu B. Impact of climate change on human infectious diseases: empirical evidence and human adaptation. Environ Int. 2016;86:14\u201323.","journal-title":"Environ Int"},{"key":"1073_CR5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1172\/JCI135003","volume":"130","author":"A Casadevall","year":"2020","unstructured":"Casadevall A. Climate change brings the specter of new infectious diseases. J Clin Investig. 2020;130:553\u20135.","journal-title":"J Clin Investig"},{"key":"1073_CR6","unstructured":"Nation Health Commission of China. An updated catalogue of microbial pathogens transmitted to humans 2022. http:\/\/www.nhc.gov.cn\/wjw\/yjzj\/202112\/94fcc4480ea2403e9c51c641645d6c20.shtml. Accessed 20 Feb\u00a02023."},{"key":"1073_CR7","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/s41564-022-01172-2","volume":"7","author":"M Hoenigl","year":"2022","unstructured":"Hoenigl M, Seidel D, Sprute R, Cunha C, Oliverio M, Goldman GH, et al. COVID-19-associated fungal infections. Nat Microbiol. 2022;7:1127\u201340.","journal-title":"Nat Microbiol"},{"key":"1073_CR8","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1016\/S2666-5247(20)30027-6","volume":"1","author":"PE Verweij","year":"2020","unstructured":"Verweij PE, Gangneux J-P, Bassetti M, Br\u00fcggemann RJ, Cornely OA, Koehler P, et al. Diagnosing COVID-19-associated pulmonary aspergillosis. Lancet Microbe. 2020;1:e53\u20135.","journal-title":"Lancet Microbe"},{"key":"1073_CR9","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1016\/S2213-2600(21)00265-4","volume":"9","author":"A Raut","year":"2021","unstructured":"Raut A, Huy NT. Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave? Lancet Respir Med. 2021;9:e77.","journal-title":"Lancet Respir Med"},{"key":"1073_CR10","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.cmi.2020.06.025","volume":"26","author":"S Hughes","year":"2020","unstructured":"Hughes S, Troise O, Donaldson H, Mughal N, Moore LSP. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clin Microbiol Infect. 2020;26:1395\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"1073_CR11","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1016\/j.cell.2022.09.015","volume":"185","author":"AB Dohlman","year":"2022","unstructured":"Dohlman AB, Klug J, Mesko M, Gao IH, Lipkin SM, Shen X, et al. A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors. Cell. 2022;185:3807\u201322.","journal-title":"Cell"},{"key":"1073_CR12","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1016\/j.cell.2022.09.005","volume":"185","author":"L Narunsky-Haziza","year":"2022","unstructured":"Narunsky-Haziza L, Sepich-Poore GD, Livyatan I, Asraf O, Martino C, Nejman D, et al. Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions. Cell. 2022;185:3789\u2013806.","journal-title":"Cell"},{"key":"1073_CR13","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1126\/science.aap7999","volume":"360","author":"MC Fisher","year":"2018","unstructured":"Fisher MC, Hawkins NJ, Sanglard D, Gurr SJ. Worldwide emergence of resistance to antifungal drugs challenges human health and food security. Science. 2018;360:739\u201342.","journal-title":"Science"},{"key":"1073_CR14","unstructured":"Centers of Disease Control and Prevention. Antibiotic resistance threats in the United States 2019. https:\/\/www.cdc.gov\/drugresistance\/pdf\/threats-report\/2019-ar-threats-report-508.pdf. Accessed 20 Feb\u00a02023."},{"key":"1073_CR15","unstructured":"World Health Organization. WHO fungal priority pathogens list to guide research, development and public health action 2022. https:\/\/www.who.int\/publications\/i\/item\/9789240060241. Accessed 20 Feb\u00a02023."},{"key":"1073_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.fgb.2015.02.009","volume":"78","author":"F Hagen","year":"2015","unstructured":"Hagen F, Khayhan K, Theelen B, Kolecka A, Polacheck I, Sionov E, et al. Recognition of seven species in the Cryptococcus gattii\/Cryptococcus neoformans species complex. Fungal Genet Biol. 2015;78:16\u201348.","journal-title":"Fungal Genet Biol"},{"key":"1073_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-micro-020518-120210","volume":"73","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Lin J, Fan Y, Lin X. Life cycle of Cryptococcus neoformans. Annu Rev Microbiol. 2019;73:17\u201342.","journal-title":"Annu Rev Microbiol"},{"key":"1073_CR18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. Prisma extension for scoping reviews (PRISMA-SCR): checklist and explanation. Ann Intern Med. 2018;169:467\u201373.","journal-title":"Ann Intern Med"},{"key":"1073_CR19","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","volume":"23","author":"BJ Park","year":"2009","unstructured":"Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS. AIDS. 2009;23:525\u201330.","journal-title":"AIDS"},{"key":"1073_CR20","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","volume":"17","author":"R Rajasingham","year":"2017","unstructured":"Rajasingham R, Smith RM, Park BJ, Jarvis JN, Govender NP, Chiller TM, et al. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis. 2017;17:873\u201381.","journal-title":"Lancet Infect Dis"},{"key":"1073_CR21","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/S1473-3099(22)00499-6","volume":"22","author":"R Rajasingham","year":"2022","unstructured":"Rajasingham R, Govender NP, Jordan A, Loyse A, Shroufi A, Denning DW, et al. The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis. Lancet Infect Dis. 2022;22:1748\u201355.","journal-title":"Lancet Infect Dis"},{"key":"1073_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s12879-017-2415-8","volume":"17","author":"NT Huong","year":"2017","unstructured":"Huong NT, Altibi AM, Hoa NM, Tuan LA, Salman S, Morsy S, et al. Progressive cutaneous cryptococcosis complicated with meningitis in a myasthenia gravis patient on long-term immunosuppressive therapy\u2014a case report. BMC Infect Dis. 2017;17:311.","journal-title":"BMC Infect Dis"},{"key":"1073_CR23","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1186\/1757-1626-1-430","volume":"1","author":"A Abbas","year":"2008","unstructured":"Abbas A, Sikkel MB, Collins JPW, Davies CWH, Chen F. A cryptic diagnosis: disseminated cryptococcal disease presenting as an asymptomatic pulmonary nodule and a skin lesion: a case report. Cases J. 2008;1:430.","journal-title":"Cases J"},{"key":"1073_CR24","first-page":"9032958","volume":"2019","author":"A Cacacho","year":"2019","unstructured":"Cacacho A, Ashraf U, Rehmani A, Niazi M, Khaja M. Atypical radiographic presentation of Cryptococcus pneumonia in a newly diagnosed HIV patient. Case Rep Infect Dis. 2019;2019:9032958.","journal-title":"Case Rep Infect Dis"},{"key":"1073_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12882-018-0815-7","volume":"19","author":"K Chakradeo","year":"2018","unstructured":"Chakradeo K, Paul Chia YY, Liu C, Mudge DW, De Silva J. Disseminated cryptococcosis presenting initially as lower limb cellulitis in a renal transplant recipient\u2014a case report. BMC Nephrol. 2018;19:18.","journal-title":"BMC Nephrol"},{"key":"1073_CR26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1186\/s12879-015-1132-4","volume":"15","author":"M Chen","year":"2015","unstructured":"Chen M, Wang X, Yu X, Dai C, Chen D, Yu C, et al. Pleural effusion as the initial clinical presentation in disseminated cryptococcosis and fungaemia: an unusual manifestation and a literature review. BMC Infect Dis. 2015;15:385.","journal-title":"BMC Infect Dis"},{"key":"1073_CR27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2174\/1570162X20666220629124225","volume":"20","author":"IA Darazam","year":"2022","unstructured":"Darazam IA, Rabiei MM, Moradi O, Gharehbagh FJ, Roozbeh M, Nourinia R, et al. A case of fingolimod-associated cryptococcal meningitis. Curr HIV Res. 2022;20:337\u201342.","journal-title":"Curr HIV Res"},{"key":"1073_CR28","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2147\/IDR.S294299","volume":"14","author":"G Deus","year":"2021","unstructured":"Deus G, Gomez-Zorrilla S, Echeverria-Esnal D, Siverio A, Guerri-Fernandez R, Ares J, et al. Osteoarticular cryptococcosis successfully treated with high-dose liposomal amphotericin B followed by oral fluconazole. Infect Drug Resist. 2021;14:719\u201322.","journal-title":"Infect Drug Resist"},{"key":"1073_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13256-019-1982-2","volume":"13","author":"M Essouma","year":"2019","unstructured":"Essouma M, Tangie LN, Temgoua MN, Kenfack UG, Ndam AN, Danwang C. Severe clinical immunodeficiency in a patient with human immunodeficiency virus infection and relatively high CD4 counts: a case report. J Med Case Rep. 2019;13:86.","journal-title":"J Med Case Rep"},{"key":"1073_CR30","doi-asserted-by":"publisher","first-page":"e01567","DOI":"10.1016\/j.idcr.2022.e01567","volume":"29","author":"S Gough","year":"2022","unstructured":"Gough S, Borgetti S, Fernandes CR. Orthostatic hypotension as the initial presentation of disseminated cryptococcosis in a kidney transplant recipient. IDCases. 2022;29:e01567.","journal-title":"IDCases"},{"key":"1073_CR31","doi-asserted-by":"publisher","first-page":"e005037","DOI":"10.1099\/jmmcr.0.005037","volume":"3","author":"FK Kassi","year":"2016","unstructured":"Kassi FK, Bellet V, Doumbia A, Krasteva D, Drakulovski P, Kouakou GA, et al. First case of mixed infection with Cryptococcus deuterogattii and Cryptococcus neoformans VNI in an ivorian HIV-positive patient. JMM Case Rep. 2016;3:e005037.","journal-title":"JMM Case Rep"},{"key":"1073_CR32","doi-asserted-by":"publisher","first-page":"106199","DOI":"10.1016\/j.ijscr.2021.106199","volume":"85","author":"M Kuwahara","year":"2021","unstructured":"Kuwahara M, Yurugi S, Ando J, Takeuchi M, Miyata R, Harada M, et al. A case of cryptococcal necrotizing fasciitis and immune reconstitution inflammatory syndrome in a renal transplantation recipient. Int J Surg Case Rep. 2021;85:106199.","journal-title":"Int J Surg Case Rep"},{"key":"1073_CR33","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/1756-0500-7-328","volume":"7","author":"DS Liyanage","year":"2014","unstructured":"Liyanage DS, Pathberiya LPS, Gooneratne IK, Caldera MHPC, Perera PWS, Gamage R. Cryptococcal meningitis presenting with bilateral complete ophthalmoplegia: a case report. BMC Res Notes. 2014;7:328.","journal-title":"BMC Res Notes"},{"key":"1073_CR34","doi-asserted-by":"publisher","first-page":"e29902","DOI":"10.5812\/hepatmon.29902","volume":"15","author":"S Mansoor","year":"2015","unstructured":"Mansoor S, Juhardeen H, Alnajjar A, Abaalkhail F, Al-Kattan W, Alsebayel M, et al. Hyponatremia as the initial presentation of cryptococcal meningitis after liver transplantation. Hepat Mon. 2015;15:e29902.","journal-title":"Hepat Mon"},{"key":"1073_CR35","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.jiac.2019.05.003","volume":"25","author":"T Nakajima","year":"2019","unstructured":"Nakajima T, Oba Y, Takashima J, Ueno K, Kikuchi A, Yamada T, et al. Cryptococcus endocarditis: a case report and review of the literature. J Infect Chemother. 2019;25:901\u20135.","journal-title":"J Infect Chemother"},{"key":"1073_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2369-14-20","volume":"14","author":"W Ni","year":"2013","unstructured":"Ni W, Huang Q, Cui J. Disseminated cryptococcosis initially presenting as cellulitis in a patient suffering from nephrotic syndrome. BMC Nephrol. 2013;14:20.","journal-title":"BMC Nephrol"},{"key":"1073_CR37","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/1471-2334-10-239","volume":"10","author":"C Probst","year":"2010","unstructured":"Probst C, Pongratz G, Capellino S, Szeimies RM, Sch\u00f6lmerich J, Fleck M, et al. Cryptococcosis mimicking cutaneous cellulitis in a patient suffering from rheumatoid arthritis: a case report. BMC Infect Dis. 2010;10:239.","journal-title":"BMC Infect Dis"},{"key":"1073_CR38","doi-asserted-by":"publisher","first-page":"e003608","DOI":"10.1099\/jmmcr.0.003608-0","volume":"1","author":"TE Richardson","year":"2014","unstructured":"Richardson TE, Lee NE, Cykowski MD, Chang SA, Powell SZ. Necrotizing fasciitis as the initial presentation of disseminated infection with fluconazole-resistant Cryptococcus neoformans. JMM Case Rep. 2014;1:e003608.","journal-title":"JMM Case Rep"},{"key":"1073_CR39","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/s12879-017-2459-9","volume":"17","author":"Q Ruan","year":"2017","unstructured":"Ruan Q, Zhu Y, Chen S, Zhu L, Zhang S, Zhang W. Disseminated cryptococcosis with recurrent multiple abscesses in an immunocompetent patient: a case report and literature review. BMC Infect Dis. 2017;17:369.","journal-title":"BMC Infect Dis"},{"key":"1073_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12879-020-05703-2","volume":"21","author":"N Sayabovorn","year":"2021","unstructured":"Sayabovorn N, Chongtrakool P, Chayakulkeeree M. Cryptococcal fungemia and Mycobacterium haemophilum cellulitis in a patient receiving ruxolitinib: a case report and literature review. BMC Infect Dis. 2021;21:27.","journal-title":"BMC Infect Dis"},{"key":"1073_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12883-017-0934-y","volume":"17","author":"Y Shimoda","year":"2017","unstructured":"Shimoda Y, Ohtomo S, Arai H, Ohtoh T, Tominaga T. Subarachnoid small vein occlusion due to inflammatory fibrosis\u2014a possible mechanism for cerebellar infarction in cryptococcal meningoencephalitis: a case report. BMC Neurol. 2017;17:157.","journal-title":"BMC Neurol"},{"key":"1073_CR42","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12883-022-02773-4","volume":"22","author":"X-H Su","year":"2022","unstructured":"Su X-H, Li W-P, Lin Q, Zheng X-J, Fang T, Jiang Y, et al. Case report: a special case of cryptococcal infection-related inflammatory syndrome in a non-HIV infected and non-transplant patient. BMC Neurol. 2022;22:247.","journal-title":"BMC Neurol"},{"key":"1073_CR43","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1186\/s12879-019-4453-x","volume":"19","author":"CS Thornton","year":"2019","unstructured":"Thornton CS, Larios O, Grossman J, Griener TP, Vaughan S. Pulmonary Cryptococcus infections as a manifestation of idiopathic CD4 lymphocytopenia: case report and literature review. BMC Infect Dis. 2019;19:862.","journal-title":"BMC Infect Dis"},{"key":"1073_CR44","doi-asserted-by":"publisher","first-page":"84","DOI":"10.15171\/jnp.2016.15","volume":"5","author":"H Trimarchi","year":"2016","unstructured":"Trimarchi H, Rengel T, Andrews J, Paulero M, Iotti A, Forastiero A, et al. Belatacept and mediastinal histoplasmosis in a kidney transplant patient. J Nephropathol. 2016;5:84\u20137.","journal-title":"J Nephropathol"},{"key":"1073_CR45","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1186\/s12879-020-05174-5","volume":"20","author":"JH van der Stoep","year":"2020","unstructured":"van der Stoep JH, Sigstad E, Bredberg A. Sarcoidosis with cryptococcal infection apparently engaging only immune-privileged body compartments: a case report. BMC Infect Dis. 2020;20:440.","journal-title":"BMC Infect Dis"},{"key":"1073_CR46","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12879-019-3831-8","volume":"19","author":"HT Vechi","year":"2019","unstructured":"Vechi HT, Theodoro RC, de Oliveira AL, Gomes RM, Soares RD, Freire MG, et al. Invasive fungal infection by Cryptococcus neoformans var. grubii with bone marrow and meningeal involvement in a HIV-infected patient: a case report. BMC Infect Dis. 2019;19:220.","journal-title":"BMC Infect Dis"},{"key":"1073_CR47","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1186\/s12879-019-4515-0","volume":"19","author":"A Wagemakers","year":"2019","unstructured":"Wagemakers A, Ang CW, Hagen F, Bot JC, Bomers MK, Visser MC, et al. Case report: chronic relapsing cryptococcal meningitis in a patient with low mannose-binding lectin and a low na\u00efve CD4 cell count. BMC Infect Dis. 2019;19:846.","journal-title":"BMC Infect Dis"},{"key":"1073_CR48","first-page":"1667","volume":"12","author":"EA Wappler-Guzzetta","year":"2022","unstructured":"Wappler-Guzzetta EA, Gray AL, Dagostino J, Kerstetter JC. Diffuse adrenal gland and pancreas necrosis in a patient with disseminated cryptococcosis\u2014case report. Life (Basel). 2022;12:1667.","journal-title":"Life (Basel)"},{"key":"1073_CR49","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12883-020-01880-4","volume":"20","author":"J Wei","year":"2020","unstructured":"Wei J, Li X-Y, Zhang Y. Central nervous system cryptococcoma mimicking demyelinating disease: a case report. BMC Neurol. 2020;20:297.","journal-title":"BMC Neurol"},{"key":"1073_CR50","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12883-020-01741-0","volume":"20","author":"T Wienemann","year":"2020","unstructured":"Wienemann T, M\u00fcller A-K, MacKenzie C, Bielor C, Weyers V, Aktas O, et al. Cryptococcal meningoencephalitis in an IGG2-deficient patient with multiple sclerosis on FINGOLIMOD therapy for more than five years\u2014case report. BMC Neurol. 2020;20:158.","journal-title":"BMC Neurol"},{"key":"1073_CR51","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12890-020-01200-z","volume":"20","author":"K Yao","year":"2020","unstructured":"Yao K, Qiu X, Hu H, Han Y, Zhang W, Xia R, et al. Pulmonary cryptococcosis coexisting with central type lung cancer in an immuocompetent patient: a case report and literature review. BMC Pulm Med. 2020;20:161.","journal-title":"BMC Pulm Med"},{"key":"1073_CR52","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/1757-1626-2-170","volume":"2","author":"BR Yehia","year":"2009","unstructured":"Yehia BR, Eberlein M, Sisson SD, Hager DN. Disseminated cryptococcosis with meningitis, peritonitis, and cryptococcemia in a HIV-negative patient with cirrhosis: a case report. Cases J. 2009;2:170.","journal-title":"Cases J"},{"key":"1073_CR53","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1186\/s12879-019-4634-7","volume":"19","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Cooper B, Gui X, Sherer R, Cao Q. Clinical diversity of invasive cryptococcosis in AIDS patients from Central China: report of two cases with review of literature. BMC Infect Dis. 2019;19:1003.","journal-title":"BMC Infect Dis"},{"key":"1073_CR54","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1186\/s12879-019-4343-2","volume":"19","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Zhang SX, Trivedi J, Toll AD, Brahmer J, Hales R, et al. Pleural fluid secondary to pulmonary cryptococcal infection: a case report and review of the literature. BMC Infect Dis. 2019;19:710.","journal-title":"BMC Infect Dis"},{"key":"1073_CR55","doi-asserted-by":"publisher","first-page":"5753","DOI":"10.2147\/IDR.S381730","volume":"15","author":"M Zhu","year":"2022","unstructured":"Zhu M, Wang Q, Wang M, Wang S, Gong Q, Zhang X, et al. Rare hepatic cryptococcosis mimicked metastatic liver cancer and confirmed by metagenomic next-generation sequencing in an immunocompetent patient: a case report. Infect Drug Resist. 2022;15:5753\u20138.","journal-title":"Infect Drug Resist"},{"key":"1073_CR56","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1086\/518607","volume":"45","author":"T Bicanic","year":"2007","unstructured":"Bicanic T, Meintjes G, Wood R, Hayes M, Rebe K, Bekker L-G, et al. Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole. Clin Infect Dis. 2007;45:76\u201380.","journal-title":"Clin Infect Dis"},{"key":"1073_CR57","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/S0140-6736(04)16301-0","volume":"363","author":"AE Brouwer","year":"2004","unstructured":"Brouwer AE, Rajanuwong A, Chierakul W, Griffin GE, Larsen RA, White NJ, et al. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Lancet. 2004;363:1764\u20137.","journal-title":"Lancet"},{"key":"1073_CR58","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3201\/eid2001.130906","volume":"20","author":"DR Boulware","year":"2014","unstructured":"Boulware DR, Rolfes MA, Rajasingham R, von Hohenberg M, Qin Z, Taseera K, et al. Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast. Emerg Infect Dis. 2014;20:45\u201353.","journal-title":"Emerg Infect Dis"},{"key":"1073_CR59","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/mmy\/myv104","volume":"54","author":"J Dyal","year":"2016","unstructured":"Dyal J, Akampurira A, Rhein J, Morawski BM, Kiggundu R, Nabeta HW, et al. Reproducibility of CSF quantitative culture methods for estimating rate of clearance in cryptococcal meningitis. Med Mycol. 2016;54:361\u20139.","journal-title":"Med Mycol"},{"key":"1073_CR60","doi-asserted-by":"publisher","first-page":"e1007914","DOI":"10.1371\/journal.ppat.1007914","volume":"15","author":"X Ye","year":"2019","unstructured":"Ye X, Gui X, Freed DC, Ku Z, Li L, Chen Y, et al. Identification of adipocyte plasma membrane-associated protein as a novel modulator of human cytomegalovirus infection. PLoS Pathog. 2019;15:e1007914.","journal-title":"PLoS Pathog"},{"key":"1073_CR61","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/cid\/cir613","volume":"53","author":"JN Jarvis","year":"2011","unstructured":"Jarvis JN, Percival A, Bauman S, Pelfrey J, Meintjes G, Williams GN, et al. Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis. Clin Infect Dis. 2011;53:1019\u201323.","journal-title":"Clin Infect Dis"},{"key":"1073_CR62","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1128\/CVI.05052-11","volume":"18","author":"A Percival","year":"2011","unstructured":"Percival A, Thorkildson P, Kozel TR. Monoclonal antibodies specific for immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, reduce serotype bias in an immunoassay for cryptococcal antigen. Clin Vaccine Immunol. 2011;18:1292\u20136.","journal-title":"Clin Vaccine Immunol"},{"key":"1073_CR63","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/cid\/cit641","volume":"58","author":"T Kabanda","year":"2013","unstructured":"Kabanda T, Siedner MJ, Klausner JD, Muzoora C, Boulware DR. Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid. Clin Infect Dis. 2013;58:113\u20136.","journal-title":"Clin Infect Dis"},{"key":"1073_CR64","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1093\/cid\/cix872","volume":"66","author":"RM Wake","year":"2017","unstructured":"Wake RM, Britz E, Sriruttan C, Rukasha I, Omar T, Spencer DC, et al. High cryptococcal antigen titers in blood are predictive of subclinical cryptococcal meningitis among human immunodeficiency virus-infected patients. Clin Infect Dis. 2017;66:686\u201392.","journal-title":"Clin Infect Dis"},{"key":"1073_CR65","doi-asserted-by":"publisher","first-page":"e00441","DOI":"10.1128\/JCM.00441-20","volume":"58","author":"JN Jarvis","year":"2020","unstructured":"Jarvis JN, Tenforde MW, Lechiile K, Milton T, Boose A, Leeme TB, et al. Evaluation of a novel semiquantitative cryptococcal antigen lateral flow assay in patients with advanced HIV disease. J Clin Microbiol. 2020;58:e00441\u201320.","journal-title":"J Clin Microbiol"},{"key":"1073_CR66","doi-asserted-by":"publisher","first-page":"e02046","DOI":"10.1128\/JCM.02046-19","volume":"58","author":"C Skipper","year":"2020","unstructured":"Skipper C, Tadeo K, Martyn E, Nalintya E, Rajasingham R, Meya DB, et al. Evaluation of serum cryptococcal antigen testing using two novel semiquantitative lateral flow assays in persons with cryptococcal antigenemia. J Clin Microbiol. 2020;58:e02046\u201319.","journal-title":"J Clin Microbiol"},{"key":"1073_CR67","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/S0140-6736(03)14472-8","volume":"362","author":"DW Denning","year":"2003","unstructured":"Denning DW. Echinocandin antifungal drugs. Lancet. 2003;362:1142\u201351.","journal-title":"Lancet"},{"key":"1073_CR68","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1021\/acs.chemrev.0c00199","volume":"121","author":"Y Lee","year":"2020","unstructured":"Lee Y, Puumala E, Robbins N, Cowen LE. Antifungal drug resistance: molecular mechanisms in Candida albicans and beyond. Chem Rev. 2020;121:3390\u2013411.","journal-title":"Chem Rev"},{"key":"1073_CR69","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1086\/649858","volume":"50","author":"JR Perfect","year":"2010","unstructured":"Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious Diseases Society of America. Clin Infect Dis. 2010;50:291\u2013322.","journal-title":"Clin Infect Dis"},{"key":"1073_CR70","unstructured":"World Health Organization. Guidelines for the diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children 2018. https:\/\/www.who.int\/publications\/i\/item\/9789241550277. Accessed 20 Feb\u00a02023."},{"key":"1073_CR71","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s40800-016-0028-6","volume":"3","author":"M Fleury","year":"2016","unstructured":"Fleury M, Fonzo-Christe C, Normand C, Bonnabry P. Confusion between two amphotericin B formulations leading to a paediatric rehospitalisation. Drug Saf Case Rep. 2016;3:4.","journal-title":"Drug Saf Case Rep"},{"key":"1073_CR72","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s40265-016-0538-7","volume":"76","author":"NR Stone","year":"2016","unstructured":"Stone NR, Bicanic T, Salim R, Hope W. Liposomal amphotericin B (AmBisome\u00ae): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions. Drugs. 2016;76:485\u2013500.","journal-title":"Drugs"},{"key":"1073_CR73","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1056\/NEJMoa2111904","volume":"386","author":"JN Jarvis","year":"2022","unstructured":"Jarvis JN, Lawrence DS, Meya DB, Kagimu E, Kasibante J, Mpoza E, et al. Single-dose liposomal amphotericin B treatment for cryptococcal meningitis. N Engl J Med. 2022;386:1109\u201320.","journal-title":"N Engl J Med"},{"key":"1073_CR74","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.bbmt.2005.10.010","volume":"12","author":"P Mehta","year":"2006","unstructured":"Mehta P, Vinks A, Filipovich A, Vaughn G, Fearing D, Sper C, et al. High-dose weekly ambisome antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study. Biol Blood Marrow Transplant. 2006;12:235\u201340.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1073_CR75","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. Grade guidelines: 8. Rating the quality of evidence\u2014indirectness. J Clin Epidemiol. 2011;64:1303\u201310.","journal-title":"J Clin Epidemiol"},{"key":"1073_CR76","unstructured":"World Health Organization. Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV 2022. https:\/\/www.who.int\/publications\/i\/item\/9789240052178. Accessed 20 Feb\u00a02023."},{"key":"1073_CR77","first-page":"566","volume":"3","author":"M Oura","year":"1955","unstructured":"Oura M, Sternberg TH, Wright ET. A new antifungal antibiotic, amphotericin B. Antibiot Annu. 1955;3:566\u201373.","journal-title":"Antibiot Annu"},{"issue":"Suppl 1","key":"1073_CR78","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/jac\/49.suppl_1.7","volume":"49","author":"D Ellis","year":"2002","unstructured":"Ellis D. Amphotericin B: spectrum and resistance. J Antimicrob Chemother. 2002;49(Suppl 1):7\u201310.","journal-title":"J Antimicrob Chemother"},{"key":"1073_CR79","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1073\/pnas.1117280109","volume":"109","author":"KC Gray","year":"2012","unstructured":"Gray KC, Palacios DS, Dailey I, Endo MM, Uno BE, Wilcock BC, et al. Amphotericin primarily kills yeast by simply binding ergosterol. Proc Natl Acad Sci USA. 2012;109:2234\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1073_CR80","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1053\/jinf.2000.0747","volume":"41","author":"CB Moore","year":"2000","unstructured":"Moore CB, Sayers N, Mosquera J, Slaven J, Denning DW. Antifungal drug resistance in Aspergillus. J Infect. 2000;41:203\u201320.","journal-title":"J Infect"},{"key":"1073_CR81","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1128\/CMR.14.4.643-658.2001","volume":"14","author":"JH Rex","year":"2001","unstructured":"Rex JH, Pfaller MA, Walsh TJ, Chaturvedi V, Espinel-Ingroff A, Ghannoum MA, et al. Antifungal susceptibility testing: practical aspects and current challenges. Clin Microbiol Rev. 2001;14:643\u201358.","journal-title":"Clin Microbiol Rev"},{"key":"1073_CR82","first-page":"307","volume":"49","author":"AB Khyriem","year":"2006","unstructured":"Khyriem AB, Sujatha S, Parija SC. Antifungal susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole. Indian J Pathol Microbiol. 2006;49:307\u20138.","journal-title":"Indian J Pathol Microbiol"},{"key":"1073_CR83","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.riam.2009.02.001","volume":"26","author":"AI Arechavala","year":"2009","unstructured":"Arechavala AI, Ochiuzzi ME, Borgnia MD, Santiso GM. Fluconazole and amphotericin B susceptibility testing of Cryptococcus neoformans: results of minimal inhibitory concentrations against 265 isolates from HIV-positive patients before and after two or more months of antifungal therapy. Rev Iberoam Micol. 2009;26:194\u20137.","journal-title":"Rev Iberoam Micol"},{"key":"1073_CR84","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1128\/JCM.36.10.2817-2822.1998","volume":"36","author":"M Lozano-Chiu","year":"1998","unstructured":"Lozano-Chiu M, Paetznick VL, Ghannoum MA, Rex JH. Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodologies. J Clin Microbiol. 1998;36:2817\u201322.","journal-title":"J Clin Microbiol"},{"key":"1073_CR85","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1054\/drup.1999.0090","volume":"2","author":"JR Perfect","year":"1999","unstructured":"Perfect JR, Cox GM. Drug resistance in Cryptococcus neoformans. Drug Resist Updates. 1999;2:259\u201369.","journal-title":"Drug Resist Updates"},{"key":"1073_CR86","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1574-6968.1994.tb07140.x","volume":"122","author":"SL Kelly","year":"1994","unstructured":"Kelly SL, Lamb DC, Taylor M, Corran AJ, Baldwin BC, Powderly WG. Resistance to amphotericin B associated with defective sterol \u22068\u21927 isomerase in a Cryptococcus neoformans strain from an AIDS patient. FEMS Microbiol Lett. 1994;122:39\u201342.","journal-title":"FEMS Microbiol Lett"},{"key":"1073_CR87","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/02681219680000381","volume":"34","author":"T Joseph-Horne","year":"1996","unstructured":"Joseph-Horne T, Loeffler RS, Hollomon DW, Kelly SL. Amphotericin B resistant isolates of Cryptococcus neoformans without alteration in sterol biosynthesis. J Med Vet Mycol. 1996;34:223\u20135.","journal-title":"J Med Vet Mycol"},{"key":"1073_CR88","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.micinf.2011.01.015","volume":"13","author":"F Sangalli-Leite","year":"2011","unstructured":"Sangalli-Leite F, Scorzoni L, Mesa-Arango AC, Casas C, Herrero E, Soares Mendes Gianinni MJ, et al. Amphotericin B mediates killing in Cryptococcus neoformans through the induction of a strong oxidative burst. Microbes Infect. 2011;13:457\u201367.","journal-title":"Microbes Infect"},{"key":"1073_CR89","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/mmy.38.3.201.207","volume":"38","author":"L Rodero","year":"2000","unstructured":"Rodero L, Cordoba S, Cahn P, Soria M, Lucarini M, Davel G, et al. Timed-kill curves for Cryptococcus neoformans isolated from patients with AIDS. Med Mycol. 2000;38:201\u20137.","journal-title":"Med Mycol"},{"key":"1073_CR90","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11046-015-9871-8","volume":"179","author":"S C\u00f3rdoba","year":"2015","unstructured":"C\u00f3rdoba S, Vivot W, Szusz W, Isla G, Davel G. Comparison of different in vitro tests to detect Cryptococcus neoformans not susceptible to amphotericin B. Mycopathologia. 2015;179:359\u201371.","journal-title":"Mycopathologia"},{"key":"1073_CR91","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.1021\/ja01573a087","volume":"79","author":"R Duschinsky","year":"1957","unstructured":"Duschinsky R, Pleven E, Heidelberger C. The synthesis of 5-fluoropyrimidines. J Am Chem Soc. 1957;79:4559\u201360.","journal-title":"J Am Chem Soc"},{"key":"1073_CR92","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1001\/jama.1968.03150040042009","volume":"206","author":"D Tassel","year":"1968","unstructured":"Tassel D. Treatment of candida sepsis and Cryptococcus meningitis with 5-fluorocytosine. JAMA. 1968;206:830.","journal-title":"JAMA"},{"key":"1073_CR93","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000221854","volume":"21","author":"A Polak","year":"1975","unstructured":"Polak A, Scholer HJ. Mode of action of 5-fluorocytosine and mechanisms of resistance. Chemotherapy. 1975;21:113\u201330.","journal-title":"Chemotherapy"},{"key":"1073_CR94","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/jac\/46.2.171","volume":"46","author":"A Vermes","year":"2000","unstructured":"Vermes A. Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J Antimicrob Chemother. 2000;46:171\u20139.","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 1","key":"1073_CR95","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.amjmed.2011.11.001","volume":"125","author":"MA Pfaller","year":"2012","unstructured":"Pfaller MA. Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am J Med. 2012;125(Suppl 1):3\u201313.","journal-title":"Am J Med"},{"key":"1073_CR96","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1007\/s10096-004-1136-2","volume":"23","author":"J Chandenier","year":"2004","unstructured":"Chandenier J, Adou-Bryn KD, Douchet C, Sar B, Kombila M, Swinne D, et al. In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia. Eur J Clin Microbiol Infect Dis. 2004;23:506\u20138.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1073_CR97","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1128\/AAC.47.10.3361-3364.2003","volume":"47","author":"P Schwarz","year":"2003","unstructured":"Schwarz P, Dromer Fran\u00e7oise, Lortholary O, Dannaoui E. In vitro interaction of flucytosine with conventional and new antifungals against Cryptococcus neoformans clinical isolates. Antimicrob Agents Chemother. 2003;47:3361\u20134.","journal-title":"Antimicrob Agents Chemother"},{"key":"1073_CR98","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1128\/AAC.50.1.113-120.2006","volume":"50","author":"P Schwarz","year":"2006","unstructured":"Schwarz P, Dromer Fran\u00e7oise, Lortholary O, Dannaoui E. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis. Antimicrob Agents Chemother. 2006;50:113\u201320.","journal-title":"Antimicrob Agents Chemother"},{"key":"1073_CR99","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1128\/AAC.00446-06","volume":"51","author":"P Schwarz","year":"2007","unstructured":"Schwarz P, Janbon G, Dromer Fran\u00e7oise, Lortholary O, Dannaoui E. Combination of amphotericin B with flucytosine is active in vitro against flucytosine-resistant isolates of Cryptococcus neoformans. Antimicrob Agents Chemother. 2007;51:383\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"1073_CR100","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1128\/AAC.48.11.4377-4386.2004","volume":"48","author":"WW Hope","year":"2004","unstructured":"Hope WW, Tabernero L, Denning DW, Anderson MJ. Molecular mechanisms of primary resistance to flucytosine in Candida albicans. Antimicrob Agents Chemother. 2004;48:4377\u201386.","journal-title":"Antimicrob Agents Chemother"},{"key":"1073_CR101","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1128\/AAC.00824-06","volume":"51","author":"N Papon","year":"2007","unstructured":"Papon N, No\u00ebl T, Florent M, Gibot-Leclerc S, Jean D, Chastin C, et al. Molecular mechanism of flucytosine resistance in Candida lusitaniae: contribution of the FCY2, FCY1, and FUR1 genes to 5-fluorouracil and fluconazole cross-resistance. Antimicrob Agents Chemother. 2007;51:369\u201371.","journal-title":"Antimicrob Agents Chemother"},{"key":"1073_CR102","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.1128\/AAC.00607-09","volume":"53","author":"BA McManus","year":"2009","unstructured":"McManus BA, Moran GP, Higgins JA, Sullivan DJ, Coleman DC. A Ser29Leu substitution in the cytosine deaminase Fca1p is responsible for clade-specific flucytosine resistance in Candida dubliniensis. Antimicrob Agents Chemother. 2009;53:4678\u201385.","journal-title":"Antimicrob Agents Chemother"},{"key":"1073_CR103","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1534\/g3.116.037499","volume":"7","author":"J Rhodes","year":"2017","unstructured":"Rhodes J, Beale MA, Vanhove M, Jarvis JN, Kannambath S, Simpson JA, et al. A population genomics approach to assessing the genetic basis of within-host microevolution underlying recurrent cryptococcal meningitis infection. G3 (Bethesda). 2017;7:1165\u201376.","journal-title":"G3 (Bethesda)"},{"key":"1073_CR104","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41467-019-13890-z","volume":"11","author":"RB Billmyre","year":"2020","unstructured":"Billmyre RB, Applen Clancey S, Li LX, Doering TL, Heitman J. 5-Fluorocytosine resistance is associated with hypermutation and alterations in capsule biosynthesis in Cryptococcus. Nat Commun. 2020;11:127.","journal-title":"Nat Commun"},{"key":"1073_CR105","doi-asserted-by":"publisher","first-page":"9973","DOI":"10.1073\/pnas.2001451117","volume":"117","author":"A Gusa","year":"2020","unstructured":"Gusa A, Williams JD, Cho J-E, Averette AF, Sun S, Shouse EM, et al. Transposon mobilization in the human fungal pathogen Cryptococcus is mutagenic during infection and promotes drug resistance in vitro. Proc Natl Acad Sci USA. 2020;117:9973\u201380.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1073_CR106","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1177\/106002809002400914","volume":"24","author":"MT Pasko","year":"1990","unstructured":"Pasko MT, Piscitelli SC, Van Slooten AD. Fluconazole: a new triazole antifungal agent. DICP. 1990;24:860\u20137.","journal-title":"DICP"},{"key":"1073_CR107","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/myc.12747","volume":"61","author":"F Bongomin","year":"2018","unstructured":"Bongomin F, Oladele RO, Gago S, Moore CB, Richardson MD. A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species. Mycoses. 2018;61:290\u20137.","journal-title":"Mycoses"},{"key":"1073_CR108","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1172\/JCI124516","volume":"129","author":"NRH Stone","year":"2019","unstructured":"Stone NRH, Rhodes J, Fisher MC, Mfinanga S, Kivuyo S, Rugemalila J, et al. Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis. J Clin Investig. 2019;129:999\u20131014.","journal-title":"J Clin Investig"},{"key":"1073_CR109","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1128\/AAC.00295-09","volume":"53","author":"E Sionov","year":"2009","unstructured":"Sionov E, Chang YC, Garraffo HM, Kwon-Chung KJ. Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence. Antimicrob Agents Chemother. 2009;53:2804\u201315.","journal-title":"Antimicrob Agents Chemother"},{"key":"1073_CR110","doi-asserted-by":"publisher","first-page":"e1000848","DOI":"10.1371\/journal.ppat.1000848","volume":"6","author":"E Sionov","year":"2010","unstructured":"Sionov E, Lee H, Chang YC, Kwon-Chung KJ. Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes. PLoS Pathog. 2010;6:e1000848.","journal-title":"PLoS Pathog"},{"key":"1073_CR111","doi-asserted-by":"publisher","first-page":"5127","DOI":"10.1128\/AAC.00694-13","volume":"57","author":"E Sionov","year":"2013","unstructured":"Sionov E, Chang YC, Kwon-Chung KJ. Azole heteroresistance in Cryptococcus neoformans: emergence of resistant clones with chromosomal disomy in the mouse brain during fluconazole treatment. Antimicrob Agents Chemother. 2013;57:5127\u201330.","journal-title":"Antimicrob Agents Chemother"},{"key":"1073_CR112","doi-asserted-by":"publisher","first-page":"e33022","DOI":"10.1371\/journal.pone.0033022","volume":"7","author":"P Ngamskulrungroj","year":"2012","unstructured":"Ngamskulrungroj P, Chang Y, Hansen B, Bugge C, Fischer E, Kwon-Chung KJ. Characterization of the chromosome 4 genes that affect fluconazole-induced disomy formation in Cryptococcus neoformans. PLoS ONE. 2012;7:e33022.","journal-title":"PLoS ONE"},{"key":"1073_CR113","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/myc.12543","volume":"60","author":"S Gago","year":"2016","unstructured":"Gago S, Serrano C, Alastruey-Izquierdo A, Cuesta I, Mart\u00edn-Mazuelos E, Aller AI, et al. Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville,\u00a0Spain. Mycoses. 2016;60:40\u201350.","journal-title":"Mycoses"},{"key":"1073_CR114","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1128\/AAC.47.11.3653-3656.2003","volume":"47","author":"L Rodero","year":"2003","unstructured":"Rodero L, Mellado E, Rodriguez AC, Salve A, Guelfand L, Cahn P, et al. G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate. Antimicrob Agents Chemother. 2003;47:3653\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"1073_CR115","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1358\/dot.2015.51.12.2421058","volume":"51","author":"LR Peyton","year":"2015","unstructured":"Peyton LR, Gallagher S, Hashemzadeh M. Triazole antifungals: a review. Drugs Today (Barc). 2015;51:705\u201318.","journal-title":"Drugs Today (Barc)"},{"key":"1073_CR116","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s13318-018-0513-7","volume":"44","author":"Z Jovi\u0107","year":"2019","unstructured":"Jovi\u0107 Z, Jankovi\u0107 SM, Ru\u017ei\u0107 Ze\u010devi\u0107 D, Milovanovi\u0107 D, Stefanovi\u0107 S, Foli\u0107 M, et al. Clinical pharmacokinetics of second-generation triazoles for the treatment of invasive aspergillosis and candidiasis. Eur J Drug Metab Pharmacokinet. 2019;44:139\u201357.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"1073_CR117","doi-asserted-by":"publisher","first-page":"e00478","DOI":"10.1128\/mBio.00478-16","volume":"7","author":"W Huang","year":"2016","unstructured":"Huang W, Liao G, Baker GM, Wang Y, Lau R, Paderu P, et al. Lipid flippase subunit Cdc50 mediates drug resistance and virulence in Cryptococcus neoformans. mBio. 2016;7:e00478-16.","journal-title":"mBio"},{"key":"1073_CR118","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1128\/JB.181.2.444-453.1999","volume":"181","author":"JR Thompson","year":"1999","unstructured":"Thompson JR, Douglas CM, Li W, Jue CK, Pramanik B, Yuan X, et al. A glucan synthase FKS1 homolog in Cryptococcus neoformans is single copy and encodes an essential function. J Bacteriol. 1999;181:444\u201353.","journal-title":"J Bacteriol"},{"key":"1073_CR119","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1128\/AAC.49.7.2851-2856.2005","volume":"49","author":"MA Maligie","year":"2005","unstructured":"Maligie MA, Selitrennikoff CP. Cryptococcus neoformans resistance to echinocandins: (1,3)beta-glucan synthase activity is sensitive to echinocandins. Antimicrob Agents Chemother. 2005;49:2851\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"1073_CR120","doi-asserted-by":"publisher","first-page":"e01952","DOI":"10.1128\/mBio.01952-19","volume":"10","author":"C Cao","year":"2019","unstructured":"Cao C, Wang Y, Husain S, Soteropoulos P, Xue C. A mechanosensitive channel governs lipid flippase-mediated echinocandin resistance in Cryptococcus neoformans. mBio. 2019;10:e01952\u201319.","journal-title":"mBio"},{"key":"1073_CR121","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1534\/genetics.119.302290","volume":"213","author":"KM Pianalto","year":"2019","unstructured":"Pianalto KM, Billmyre RB, Telzrow CL, Alspaugh JA. Roles for stress response and cell wall biosynthesis pathways in caspofungin tolerance in Cryptococcus neoformans. Genetics. 2019;213:213\u201327.","journal-title":"Genetics"}],"container-title":["Infectious Diseases of Poverty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-023-01073-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40249-023-01073-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-023-01073-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T22:03:16Z","timestamp":1702072996000},"score":1,"resource":{"primary":{"URL":"https:\/\/idpjournal.biomedcentral.com\/articles\/10.1186\/s40249-023-01073-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":121,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1073"],"URL":"https:\/\/doi.org\/10.1186\/s40249-023-01073-4","relation":{},"ISSN":["2049-9957"],"issn-type":[{"value":"2049-9957","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,17]]},"assertion":[{"value":"13 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}